REDUCE FMR is published in Journal of American College of Cardiology: Heart Failure. A milestone for Cardiac Dimensions and the Carillon Mitral Contour System.

Reduce FMR demonstrated the Carillon Mitral Contour System® significantly improves mitral regurgitation and slows worsening of heart failure.

The results of the 1st blinded, sham – controlled randomized clinical trial in heart valve therapy show Carillon significantly reduces mitral regurgitant volume and induces significant favorable (reverse) LV remodeling, as well as improves NYHA classification and other functional and HF assessments. 

REDUCE FMR will be in the November 1, 2019 issue of JACC HF. Attached, copy of the online publication.

The pivotal CARILLON Trial is currently enrolling sites and patients in the US, Canada and EU.

For further information, please visit our Cardiac Dimensions Website or call.